Полный текст Pdf  

УДК 617.735-007.23:616-053.32-07-08(048.8)

http://doi.org/10.31288/oftalmolzh20126101110

РЕТИНОПАТИЯ НЕДОНОШЕННЫХ: ЭТИОЛОГИЯ, ПАТОГЕНЕЗ, ДИАГНОСТИКА И ЛЕЧЕНИЕ

Н. В. Пасечникова, член- кор. НАМH Украины, профессор, д. м. н., С. В. Кацан, к. м. н.

ГУ «Институт глазных болезней и тканевой терапии им. В. П. Филатова НАМH Украины» г Одесса

СПИСОК ЛИТЕРАТУРЫ

1.Азнабаев М. Т., Ахмадеева Э. Н., Сайдашева Э. И. Ретинопатия недоношенных. — Уфа, 2000. — 180 с.

2.Ретинопатия недоношенных 2011: сборник трудов Всероссийской научно-практической конференции с международным участием. Москва, 7 апреля 2011 г. — М.: ФГУ «МНИИ ГБ им. Гельмгольца» Минздравсоц-развития России, 2011. — 247 с. + цв. Вклейка 8 с.

3.Риков С. О., Сергієнко А. М., Филипчук О. М. Хірургічне лікування ретинопатії недоношених V стадії // Метод. рекомендації. — Київ, 2007. — С. 5-24.

4.Рыков С. А. Ретинопатия недоношенных / С. А. Рыков, С. А. Сук, Н. В. Пасечникова // Офтальмол. журн. — 2003. — № 1. — С.57- 60.

5.Сердюк Н. П. Некоторые проблемы психолого-педиатрической реабилитации детей с ретинопатией недоношенных // Материалы юбилейной научной конференции детских офтальмологов. — Санкт-Петербург, 2005. — С. 172-173.

6.Сук С. А. Оптимизация тактики ведения детей с рети-нопатией недоношенных: Дисс....канд. мед. наук. — Одесса, 2006. — 5,6 с.

7.Шамшинова A. M. Наследственные и врожденные за-болевания сетчатки и зрительного нерва / М.: Медицина, 2001. — 528с.

8.A classification of retrolental fibroplasias // Am J Ophthalmol. — 1953. — 36. — Р.1333- 1335.

9.Wilkinson A. R. Haines L., Headb K., Fielder A. R. Wilkinson A, L. Haines B., Headb K., Fielder A. R. UK retinopathy of prematurity guideline // Early Human Development. — 2008. — P.84, 71-74

10.Arevalo J. F., Garcia-Amaris R. A. Intravitreal bevaci-zumab for diabetic retinopathy // Curr Diabetes Rev. — 2009. — Vol.5. — P.39- 46.

11.Wutthiworavong B., Saowaparit C. New Intravitreal Beva-cizumab Technique for Treatment of Aggressive Posterior Retinopathy (AP-ROP) // 25 th Scientific Meeting The Royal College of Ophthalmologists of Thailand. — July 16-18, 2010.

12.Benner J. D., Morse L. S., Hay A., Landers M. B., III. A comparison of argon and diode photocoagulation combined with supplemental oxygen for the treatment of retinopathy of prematurity // Retina. — 1993. — 13(3). — P.222-229.

13.Committee for the Classification of Retinopathy of Pre-maturity. An International Classification of Retinopathy of Prematurity // Arch Ophthalmol. — 1984. — 102. — P.1130-134.

14.Connolly B. P., McNamara J. A., Sharma S., Regillo C. D., Tasman W. A comparison of laser photocoagulation with trans-scleral cryotherapy in the treatment of threshold retinopathy of prematurity // Ophthalmology. — 1998. — 105(9). — P.1628- 1631.

15.Cryoterapy for Retinopathy of Prematurity Cooperative Group. The natural ocular outcome of premature birth and retinopathy // Arch Ophthalmol. — 1994. — 112. — P.903-912.

16.Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome-structure and function // Arch Ophthalmol. — 1990. — 108(10). — P.1408- 1416.

17.Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results // Arch Ophthalmol. — 1988. — 106(4). — P.471-479.

18.Cryotherapy for Retinopathy of Prematurity Cooperative Group. The natural ocular outcome of premature birth and retinopathy. Status at 1 year // Arch Ophthalmol. — 1994. — 112(7). — P.903-912.

19.Darlow B. A. Promise and potential pitfalls of anti-VEGF drugs in retinopathy of prematurity // Br J Ophthalmol. — 2009.— P.93:986.

20.Dhillon B., Wright E., Fleck B. W. Screening for retinopathy of prematurity: are a lid speculum and scleral indentation necessary? // J Pediatr Ophthalmol Strabismus. — 1993. — 30(6). — P.377-381.

21.Efficacy and safety of green laser photocoagulation for threshold retinopathy of prematurity // Arq Bras Oftalmol. — 2008. — 71(1). — P.49-51.

22.Eye (2010) 24, 931- 933; doi:10.1038/eye.2009.156; published online 26 June 2009.

23.Fielder A. R., Shaw D. E., Robinson J., Ng Y. K. Natural history of retinopathy of prematurity: a prospective study // Eye. — 1992. — 6 (Pt 3). — P.233- 242.

24.Final Visual Acuity Results in the Early Treatment for Retinopathy of Prematurity Study // Arch Ophthalmol. — 2010.— 128(6). — P.663-671.

25.Sanghi G. // Br J Ophthalmol. — 2010. — V.94. — P.1264-1265. doi:10.1136/bjo.2009.168583

26.Gallagher K., Moseley M., Tandon A., Watson M. P., Cocker K. D., Fielder A. R. Asimmetric of retinopathy of prematurity in the nasal and temporal retina // Arch Ophthalmol. — 2003. — Vol.121. — P.1563-1568.

27.Gariano R., Kalina R., Hendrickson A. Normal and patho-logical mechanisms in retinal vascular development // Surv. Ophtalmol. — 1996. — Vol. 40. № 6. — P. 481- 490.

28.Gene Emery B New England Journal of Medicine. — 2011.

29.Gilbert C., Rahi J., Eckstein M., OSullivan J., Foster A. Retinopathy of prematurity in middle-income countries // Lancet. — 1997. — V.350. — P.12-4.

30.Good W. V. Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial // Trans Am Ophthalmol Soc. — 2004. — Vol.102. — P.233-248.

31.Good W. V., Hardy R. J., Dobson V., Palmer E. A., Phelps D. L., Quintos M. et al. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study // Pediatrics. — 2005. — 116(1). — P.15-23.

32.Haines L., Fielder A. R., Baker H., Wilkinson A. R. UK population based study of severe retinopathy of prematurity: screening, treatment, and outcome // Arch Dis Child Fetal Neonatal Ed. — 2005. — 90(3). — F240-F24420.

33.Helen A. Mintz-Hittner, Kathleen A. Kennedy, M. P. H., and Alice Z. Chuang. For the BEAT-ROP Cooperative Group N // Engl J Med. — 2011. — 364:603- 615.

34.Hunter D. G., Repka M. X. Diode laser photocoagulation for threshold retinopathy ofprematurity. A randomized study // Ophthalmology. — 1993. — 100(2). — P.238-244.

35.ICROP Committee for Classification of Late Stages ROP. An international classification of retinopathy of prematurity, II: the classification of retinal detachment // Arch Ophthalmol. — 1987. — 105. — P.906- 912.

36.International Committee for the Classification of Retinopathy of Prematurity. The international classification of reti-nopathy of prematurity revisited //Arch Ophthalmol. — 2005. — 123(7). — P.991-999.

37.Jonathan A. Micieli, Michael Surkont, and Andrew F. Smith A Systematic Analysis of the Off-Label Use of Bevacizumab for Severe Retinopathy of Prematurity // American jornal of Ophthalmology. — 2009.

38.Katz X., Kychenthal A., Dorta P. Zone I retinopathy of prematurity // J AAPOS. — 2000. — 4. — P.373- 376.

39.Kushner B., Essner D., Cohen I., Flynn J. Retrolental fibroplasia, ll: pathologic correlation // Arch Ophthalmol. — 1977. — 95. — P.29-38.

40.Lalwani G. A., Berrocal A. M., Murray T. G. et al. Offlabel use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity // Retina. — 2009. — V.29. — P.127.

41.Lambert S. R., Capone A., Jr., Cingle K. A. Cataract and phthisis bulbi after laser photoablation for threshold reti-nopathy of prematurity // Am J Ophthalmol. — 2000. — 129(5). — P.585-591.

42.Machemer R. Discription and pathogenesis of late stage retinopathy of prematurity // Ophthalmology. — 1985. — Vol.92. — P. 1000-1040.

43.Marek E. Prost. Problems of the pathogenesis of ROP. — 2009, P.5.

44.McHolm J. R., Hartnett M. E. Retinopathy of prematurity: current understanding based on clinical trials and animal models // Pediatric Retina. — Philadelphia, Lippincott, Williams & Wilkins. — 2005.

45.McNamara J. A., Tasman W., Brown G. C., Federman J. L. Laser photocoagulation for stage 3+ retinopathy of prematurity // Ophthalmology. —  1991. —  98(5). — P.576- 580.

46.McNamara J. A., Tasman W., Vmder J. F., Brown G. C. Diode laser photocoagulation for retinopathy of prematurity. Preliminary results // Arch Ophthalmol. — 1992. — 110(12). — P.1714-1716.

47.Mintz-Hittner H. A., Kennedy K. A., Chuang A. Z. BEAT-ROP Cooperative Group. Efficacy of intravitreal bevaci-zumab for stage 3+ retinopathy of prematurity // N Engl J Med. — 2011. — 364(7). — P.603- 615.

48.Multicenter trial of cryotherapy for retinopathy of prema-turity. Three-month outcome. Cryotherapy for Retinopa-thy of Prematurity. Cooperative Group // Arch Ophthalmol. — 1990. — 108. — P.195-204.

49.Nagata M. Treatment of acute proliferatiove retrolental fi-broplasia with xenon arc photocagulation: its indications and limitation // Jpn J Ophthalmol. — 1970. — 21:435- 459.

50.Ng E. Y., Connolly B. P., McNamara J. A., Regillo C. D., Vander J. F., Tasman W. A comparison of laser photoco-agulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 1. Visual function and structural outcome // Ophthalmology. — 2002. — 109(5). — P.928-934.

51.O'Connor A. R., Stewart C. E., Singh J., Fielder A. R. Do infants of birth weight less than 1500g require additional long term ophthalmic follow-up? // Br J Ophthalmol. — 2006. — V.90. — P.451-455.96.

52.Ola Didrik Saugstad, Retinopathy of Prematurity: What Is New? Oslo, Norway // Neonatology. — 2011. — 100(1). — P.1-8.

53.Owens W. S., Owens E. U. // Am. J. Opthalmol. — 1949. — Vol. 32. —P. 1-21.

54.Palmer E., Flynn J., Hardy R. et al. Incidence and early course of retinopathy of prematurity // Ophthalmology. — 1991. — V.98. — P.1628- 1638.

55.Palmer E. A., Flynn J. T., Hardy R. J., Phelps D. L., Phillips C. L., Schaffer D. B. et al. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Reti-nopathy of Prematurity Cooperative Group // Ophthalmology. — 1991. — 98(11). — P. 1628- 1640.

56.Palmer E. A., Hardy R. J., Dobson V., Phelps D. L., Quinn G. E., Summers C. G. et al, Cryotherapy for Retinopathy of Prematurity Cooperative Group.. 15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity // Arch Ophthalmol. — 2005. — 123(3). — P.311-318.

57.Parag K. Shah, V. Narendran, V. R. Saravanan, A. Ra-ghuram, Abhijit Chattopadhyay, Maithreyi Kashyap. Screening for retinopathy of prematurity—a comparison between binocularindirect ophthalmoscopy and RetCam 120, DNB // Indian J Ophthalmol. — 2006. — 54. — P.35-8.

58.Paysse E. A., Lindsey J. L., Coats D. K., Contant C. F., Jr., Steinkuller P. G.. Therapeutic outcomes of cryother-apy versus transpupillary diode laser photocoagulation for threshold retinopathy of prematurity // J AAPOS. — 1999. — 3(4). — P.234-240.

59.Phan M. H., Nguyen P. N., Reynolds J. D. Incidence and severity of Retinopathy of Prematurity in Vietnam, a de-veloping middleincome country // J Pediatr Ophthalmol Stradismus. — 2003. — 40. — P.208-12.

60.Prooceedings of the 36th Annual Meeting of the European Paediatric Ophthalmological Society (EPOS) 2010. — P. 1-14.

61.Quiroz-Mercado H, Martinez-Castellanos M. A., Her-nandez-Rojas M. L. et al. Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity // Retina. — 2008. — 29. — P.127.

62.Repka M. X., Palmer E. A., Tung B. Cryotherapy for Reti-nopathy of Prematurity Cooperative Group. Involution of retinopathy of prematurity // Arch Ophthalmol. — 2000. — 118(5). — P.645- 649.

63.Repka M. X., Palmer E. A., Tung B; on behalf of the CRYO-ROP Cooperative Group. Involution of retinopathy of prematurity // Arch Ophthalmol. — 2000. — 118. — P.645-649.

64.Retinopathy of prematurity in Asian Indian babies weighing greater than 1250 grams at birth: Ten year data from a tertiary care center in a developing country // Indian J Ophthalmol. — 2007. — 55. — P.331-6.

65.Retinopathy of prematurity: Clinic and Pathogenesis // Ophthalmologica. — 2008. — 222. — P.220-224.

66.Reynolds J. D., Dobson V., Quinn G. E., Fielder A. R., Palmer E. A., Saunders R. A. et al. Evidencebased screening criteria for retinopathy of prematurity: natural history data from the CRYOROP and LIGHT-ROP studies // ArchOphthalmol. — 2002. — 120(11). — P. 1470- 1476.

67.Roth D. B., Morales D. Screening for retinopathy of prematurity employing the RetCam 120: sensitivity and specificity [abstract] // Invest. Ophtalmol. — Vis. Sci. — 1999. — Vol. 40. — P.2997-3003.

68.Royal College of Paediatrics and Child Health,Royal College of Ophthalmologists & British Association of Perinatal Medicine. — 2007. — P.1-59.

69.Schaffer D. B., Palmer E. A., Plotsky D. F., Metz H. S., Flynn J. T., Tung B. et al. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Prognostic factors in the natural course of retinopathy of prematurity // Ophthalmology. — 1993. — 100(2). — P.230- 237.

70.Schouten J. S., La Heij E. C., Webers C. A., Lundqvist I. J., Hendrikse F. A systematic review on the effect of bevaci-zumab in exudative age-related macular degeneration // Graefes Arch Clin Exp Ophthalmol. — 2009. — 247. — P.1-11.

71.Schwarz Q., Gu C., Fujisawa H. et al. Vascular endothe-lial growth factor controls neuronal migration and cooperates with Sema3A to pattern distinct compartments of the facial nerve // Genes Dev. — 2004. — 18. — P.2822- 2834.

72.Shinomiya K., Kajima M., Tajika H., Shiota H., Nakagawa R., Saijyou T. Renal failure caused by eyedrops containing phenylephrine in a case of retinopathy of prematurity // J Med Invest. — 2003. — 50(3-4). — P.203-206.

73.Terry T. L. Extreme prematurity and fibroplastic overgrowth of persistent vascular sheath behind each cristalline lens. Preliminary report // Am. J. Ophtalmol. — 1942. — Vol. 25. — P.203-204.

74.Terry T. L. Fibroplastic overgrowth of persistent tunica vasculosa lentis in premature infants. Etiologic factors // Arch. Ophtalmol. — 1943. — Vol. 29. — P.54-68.

75.Terry T. L. Retrolental fibroplasias in premature infants. Further studies on fibroplastic overgrowth of persistent tunica vasculosa lentis // Arch. Ophtalmol. —  1945. — Vol. 33. — P.203-208.

76.The International Classification of Retinopathy of Prematurity Revisited // Arch Ophthalmol. — 2005. — 123. — P.991- 999.

77.The STOP-ROP Multicenter Study Group. Supplemental therapeutic oxygen for prethreshold retinopathy of prema-turity (STOP-ROP): a randomized, controlled trial, l: primary outcomes // Pediatrics. — 2000. — 105. — P.295- 310.

78.Trese M. T. Retinopathy of prematurity. In: Ryan SJ, editor. Retina. 4th ed. Philadelphia: Elsevier-Mosby; 2006. — P. 2463- 76.

79.Usa Thitiratsanont, Chairat Saowaparit. 25 th Scientific Meeting The Royal College of Ophthalmologists of Thailand // 2010. — July 16-18.

80.Vander J., Handa J. McNamara A. et al. Early Treatment of posterior retinopathy of prematurity: a controlled trial // Ophthalmology. — 1997. — 104. — P.1731- 1736.

81.Wagner R. S. Increased incidence and severity of retinopathy of prematurity in developing nations // J Pediatr Ophthalmol Stradismus. — 2003. — 40. — P.193.

82.Young T. L., Anthony D. C., Pierce E., Foley E., Smith L. E. Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity // J AAPOS. — 1997. — 1. — P.105-110.